AI assistant
Sending…
Pulmatrix, Inc. — Director's Dealing 2014
May 13, 2014
35037_dirs_2014-05-13_32ca8b1a-e9f3-4623-9509-1d31e1fb58a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ruthigen, Inc. (RTGN)
CIK: 0001574235
Period of Report: 2014-05-11
Reporting Person: French Gregory M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-11 | Common Stock | A | 58000 | — | Acquired | 58000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-12 | Stock Option (right to buy) | $6.37 | A | 10000 | Acquired | 2024-05-12 | Common Stock (10000) | Direct |
Footnotes
F1: Grant of restricted stock units which vest at a rate of 8.34% per quarter for a three-year period beginning on May 11, 2014. The issuance of the shares of common stock will be further deferred to specified dates in accordance with Section 409A of the Internal Revenue Code.
F2: The option vests at a rate of 8.34% per quarter for a three-year period beginning on May 12, 2014.
More from Pulmatrix, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Mar 2
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Regulatory Filings
2025
Dec 18
Interim / Quarterly Report
2025
Oct 16
Regulatory Filings
2025
Oct 16
Interim / Quarterly Report
2025
Aug 6